Minipig cytochrome P450 2E1: Comparison with human enzyme

Drug Metabolism and Disposition

Volumn 33, Issue 6, 2005, Pages 862-865

  Baranová, Jana ^a   Anzenbacherová, Eva ^a   Anzenbacher, Pavel ^a   Souček, Pavel ^b  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; CHLORZOXAZONE; COMPLEMENTARY DNA; CYTOCHROME P450 2E1; DIETHYLDITHIOCARBAMIC ACID; DRUG RESIDUE; NITROPHENOL;

ANIMAL CELL; ARTICLE; CATALYSIS; CELL FRACTIONATION; CONTROLLED STUDY; DNA SEQUENCE; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME ISOLATION; ENZYME STRUCTURE; ENZYME SUBSTRATE; LIVER MICROSOME; MINIPIG; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ANIMALS; CYTOCHROME P-450 CYP2E1; HUMANS; MICROSOMES, LIVER; MOLECULAR SEQUENCE DATA; SPECIES SPECIFICITY; SWINE; SWINE, MINIATURE;

SUS SCROFA;

EID: 18844441225     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.104.003392     Document Type: Article

References (37)

1. Anzenbacher P, Soucek P, Anzenbacherová E, Gut I, Hrabý K, Svoboda Z, and Kvetina J (1998) Presence and activity of cytochrome P450 isoforms in minipig liver microsomes. Comparison with human samples. Drug Metab Dispos 26:90-93.
2. Anzenbacherova E, Baranova J, Zuber R, Pechova A, Anzenbacher P, Soucek P, and Martínkova J (2005) Model systems based on experimental animals for studies on drug metabolism in man: (mini)pig cytochromes P450 3A29 and 2E1. Basic Clin Pharmacol Toxicol 96:244-245.
3. Bogaards JJP, Bertrand M, Jackson P, Oudshoorn MJ, Weavers RJ, van Bladeren PJ, and Walther B (2000) Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man. Xenobiotica 30:1131-1152.
4. Carriere V, Goasduff T, Ratanasavanh D, Morel F, Gautier JC, Guillouzo A, Beaune P, and Berthou F (1993) Both cytochromes P450 2E1 and 1A1 are involved in the metabolism of chlorzoxazone. Chem Res Toxicol 6:852-857.
5. Chang TKH, Crespi CL, and Waxman DJ (1998) Spectrophotometric analysis of human CYP2E1-catalyzed p-nitrophenol hydroxylation. Methods Mol Biol 127:147-152.
6. Chauret N, Gauthier A, Martin J, and Nicol-Griffith DA (1997) In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat and horse. Drug Metab Dispos 25:1130-1135.
7. Court MH, von Moltke LL, Shader RI, and Greenblatt DJ (1997) Biotransformation of chlorzoxazone by hepatic microsomes from humans and ten other mammalian species. Biopharm Drug Dispos 18:213-226.
8. Couzin J (2002) Wanted: pig transplants that work. Science (Wash DC) 295:1108.
9. Desille M, Corcos L, L'Helgoualch A, Frémond B, Campion JP, Guillouzo A, and Clément B (1999) Detoxifying activity in pig livers and hepatocytes intended for xenotherapy. Transplantation 68:1437-1443.
10. Donato MT, Castell JV, and Gomez-Lechon MJ (1999) Characterization of drug metabolizing activities in pig hepatocytes for use in bioartificial liver devices. J Hepatol 31:542-549.
11. Gorski JC, Jones DR, Wrighton SA, and Hall SD (1997) Contribution of human CYP3A subfamily members to the 6-hydroxylation of chlorzoxazone. Xenobiotica 27:243-256.
12. Gotoh O (1992) Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. J Biol Chem 267:83-90.
13. Guengerich FP (1997) Comparisons of catalytic selectivity of cytochrome P450 subfamily enzymes from different species. Chem-Biol Interact 106:161-182.
14. Guengerich FP, Kim DH, and Iwasaki M (1991) Role of human cytochrome P450 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol 4:168-179.
15. Jayyosi Z, Muc M, Erick J, Thomas PE, and Kelley M (1996) Catalytic and immunochemical characterization of cytochrome P450 isoenzyme induction in dog liver. Fundam Appl Toxicol 31:95-101.
16. Johnsrud EK, Koukouritaki SB, Divakaran K, Brunengraber LL, Hines RN, and McCarver DG (2003) Human hepatic CYP2E expression during development. J Pharmacol Exp Ther 307:402-407.
17. Lake BG (1990) Preparation and characterization of microsomal fractions for studies on xenobiotic metabolism, in Biochemical Toxicology. A Practical Approach (Snell K and Mullock BJ eds) pp 183-215, IRL Press, Oxford, UK.
18. Lewis DFV, Bird MG, and Parke DV (1997) Molecular modelling of CYP2E1 enzymes from rat, mouse and man: an explanation for species differences in butadiene metabolism and potential carcinogenicity and rationalization of CYP2E substrate specificity. Toxicology 118:93-113.
19. Lewis DFV, Lake BG, Bird MG, Loizou GD, Dickins M, and Goldfarb PS (2003) Homology modelling of human CYP2E1 based on the CYP2C5 crystal structure: investigation of enzyme-substrate and enzyme-inhibitor interactions. Toxicol In Vitro 17:93-105.
20. Lieber CS (1997) Cytochrome P450 2E1: its physiological and pathological role. Physiol Rev 77:517-544.
21. Lucas D, Menez JF, and Berthou F (1996) Chlorzoxazone: an in vitro and in vivo substrate probe for liver CYP2E1. Methods Enzymol 272:115-123.
22. Madden S, Gentile DM, Crawford GA, Simpson AG, and Johnston AM (1998) Cytochrome P450 activities in hepatic microsomes from the mini pig. ISSX Proc 13:73.
23. Monostory K, Hazai E, and Vereczkey L (2004) Inhibition of cytochrome P450 enzymes participating in p-nitrophenol hydroxylation by drugs known as CYP2E1 inhibitors. Chem-Biol Interact 147:331-340.
24. Monshouwer M, van't Klooster GAE, Nijmeijer SM, Witkamp RF, and van Miert AS (1998) Characterization of cytochrome P450 isoenzymes in primary cultures of pig hepatocytes. Toxicol In Vitro 12:715-723.
25. Myers MJ, Farrell DE, Howard KD, and Kawalek JC (2001) Identification of multiple constitutive and inducible hepatic cytochrome P450 enzymes in market weight swine. Drug Metab Dispos 29:908-915.
26. Park JY and Harris D (2003) Construction and assessment of models of CYP2E1: predictions of metabolism from docking, molecular dynamics and density functional theoretical calculations. J Med Chem 46:1645-1660.
27. Sai Y, Dai R, Yang TJ, Krausz KW, Gonzalez FJ, Gelboin HV, and Shou M (2000) Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes. Xenobiotica 26:681-693.
28. Sandhu P, Baba T, and Guengerich FP (1993) Expression of modified cytochrome P450 2C10 (2C9) in Escherichia coli, purification, and reconstitution of catalytic activity, Arch Biochem Biophys 306:443-450.
29. Shimada T and Yamazaki H (1998) Cytochrome P450 reconstitution systems. Methods Mol Biol 107:85-93.
30. Skaanild M and Friis C (1999) Cytochrome P450 sex differences in minipig and conventional pig. Pharmacol Toxicol 85:174-180.
31. Soucek P, Zuber R, Anzenbacherová E, Anzenbacher P, and Guengerich FP (2001) Minipig cytochrome P450 3A, 2A and 2C enzymes have similar properties to human analogs. BMC Pharmacol 1:19.
32. Tassaneeyakul W, Veronese ME, Birkett DJ, and Miners JO (1993) High-performance liquid chromatographic assay for 4-nitrophenol hydroxylation, putative cytochrome P450 2E1 activity, in human liver microsomes. J Chromatogr 616:73-78.
33. Upadhya SC, Tirumalai PS, Boyd MR, Mori T, and Ravindranath V (2000) Cytochrome P4502E (CYP2E) in brain: constitutive expression, induction by ethanol and localization by fluorescence in situ hybridization. Arch Biochem Biophys 373:23-34.
34. Vaclavikova R, Soucek P, Svobodova L, Anzenbacher P, Simek P, Guengerich FP, and Gut I (2004) Different in vitro metabolism of paclitaxel and docetaxel in humans, rats, pigs, and minipigs. Drug Metab Dispos 32:666-674.
35. Yasukochi Y and Masters BSS (1976) Some properties of a detergent-solubilized NADPH-cytochrome c (cytochrome P450) reductase purified by biospecific affinity chromatography. J Biol Chem 251:5337-5344.
36. Zerilli A, Ratanasavanh D, Lucas D, Goasduff T, Dréano Y, Menard C, Picart D, and Berthou F (1997) Both cytochromes P450 2E1 and 3A are involved in the O-hydroxylation of p-nitrophenol, a catalytic activity known to be specific for P450 2E1. Chem Res Toxicol 10:1205-1212.
37. Zuber R, Anzenbacherová E, and Anzenbacher P (2002) Cytochromes P450 and experimental models of drug metabolism. J Cell Mol Med 6:189-198.